Home » Prices » NASDAQ:CRBP

Corbus Pharmaceuticals Holdings, Inc. stock price

Today's NASDAQ:CRBP chart, history & news

Price:
1.22 USD
Change:
+0.02 (1.67%)
Key Stats
Price open 1.22
Previous close 1.2
Market cap 102.53M
Volume 2.12M
Day high 1.22
Day low 1.18
Year high 9.38
Year low 0.9397
Year to date change -75.74%
P/E Ratio -0.67
Company Profile
Fundamentals
Insider Information
News

About Corbus Pharmaceuticals Holdings, Inc.

Corbus Pharmaceuticals Holdings, Inc. is a phase 3 clinical-stage pharmaceutical company, which focuses on the development and commercialization of novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases. The Company's lead product candidate, lenabasum, is a novel, synthetic oral endocannabinoid-mimetic drug designed to resolve chronic inflammation and fibrotic processes. Lenabasum is currently being evaluated in systemic sclerosis, cystic fibrosis, dermatomyositis, and systemic lupus erythematosus. The company was founded on December 18, 2013 and is headquartered in Norwood, MA.

Company information

Company name
Corbus Pharmaceuticals Holdings Inc
Exchange
Sector
Health Technology
Industry
Biotechnology
Employees
141
CEO
Yuval Cohen
Address
500 River Ridge Drive, Norwood, MA, 02062
Country
United States
Contact information
1.617.963.0100
Website
http://www.corbuspharma.com

Related companies

Invezz uses cookies to provide you with a great user experience. By using Invezz, you accept our privacy policy.